StonvexLoading…
StonvexStonvexStonvexCore line items from TEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-26 | Annual 2024 2024-09-27 | Annual 2023 2023-09-29 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $17.26B | $15.85B | $16.03B | $16.28B |
Operating Income | $3.21B | $2.80B | $2.30B | $2.76B |
Net Income | $1.84B | $3.19B | $1.91B | $2.43B |
EPS (Diluted) | $6.16 | $10.33 | $6.03 | $7.47 |
Total Assets | $25.08B | $22.85B | $21.71B | $20.78B |
Total Liabilities | $12.35B | $10.37B | $10.06B | $9.88B |
Cash & Equivalents | $1.25B | $1.32B | $1.66B | $1.09B |
Free Cash Flow OCF − CapEx | $3.20B | $2.80B | $2.40B | $1.70B |
Shares Outstanding | 299.00M | 309.00M | 317.00M | 325.00M |